Corrigendum to 'No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial' [European Neuropsychopharmacology 53 (2021) 34-46]
Eur Neuropsychopharmacol. 2022 Nov:64:61-62.
doi: 10.1016/j.euroneuro.2022.09.005.
Epub 2022 Oct 2.
1 Discipline of Psychiatry, Adelaide Medical School, University of Adelaide, Adelaide, Australia; Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Melbourne, Australia; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia; Department of Psychiatry and Psychotherapy, University Hospital Münster, University of Münster, Münster, Germany. Electronic address: [email protected].
2 Discipline of Psychiatry, Adelaide Medical School, University of Adelaide, Adelaide, Australia.
3 Faculty of Health Sciences, University of Adelaide, Adelaide, Australia.
4 Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
5 Discipline of Psychiatry, Adelaide Medical School, University of Adelaide, Adelaide, Australia; Northern Adelaide Mental Health Service, Salisbury, Australia.
6 Discipline of Psychiatry, Adelaide Medical School, University of Adelaide, Adelaide, Australia; Lysosomal Health in Ageing, Hopwood Centre for Neurobiology, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, Australia.